Abstract
We investigated the early efficacy and tolerability of levetiracetam as add-on therapy in refractory partial onset epilepsy. Levetiracetam was added to 61 patients at a starting dose of 250 mg b.i.d. over 15 days and data were compaired to the previous 15 days. During the baseline period the number of the seizure-free days was 646, after the 15 days of treatment was 756 (+17%; p
| Translated title of the contribution | Is Levetiracetam early effective? |
|---|---|
| Original language | Italian |
| Pages (from-to) | 179-181 |
| Number of pages | 3 |
| Journal | Bollettino - Lega Italiana contro l'Epilessia |
| Issue number | 121-122 |
| Publication status | Published - Jul 2003 |
ASJC Scopus subject areas
- Clinical Neurology